COVID-19
Conditions
Keywords
COVID-19, Osteopathic Manipulative Medicine, Antibody
Brief summary
The purpose of this project is to study the impact of Osteopathic Manipulative Medicine (OMM) treatments, such as lymphatic myofascial release and thoracic pump techniques severe acute respiratory syndrome-associated coronavirus 2 (SARS-Cov-2) antibody levels in patients who receive the mRNA-1273 (Moderna) COVID-19 vaccine and to consider if these OMM strategies allow a stronger more robust immune response.
Interventions
OTHERLymphatic OMM
Patients receive lymphatic myofascial release and thoracic pump techniques.
OTHERLight Touch
Patients receive a series of light touch techniques.
Sponsors
Rowan University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Inclusion criteria will include age greater than 18 years old and having safely received the COVID-19 vaccine.
Exclusion criteria
*
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| severe acute respiratory syndrome-associated coronavirus 2 (SARS-Cov-2) antibody levels | The day of first vaccine dose (baseline), the day of second vaccine dose (at about 4-weeks post first vaccine dose), and 2-weeks post second vaccine dose (at about 6-weeks post first vaccine dose | Antibody levels collected via blood draw |
Countries
United States
Outcome results
None listed